In diabetes, increased ACE activity elevates Angiotensin-II, through AT1 receptor activation, promotes oxidative stress, NF-κB–mediated inflammation, insulin resistance, and TGF-β–driven fibrosis (Hsueh and Wyne, 2011; Patel et al., 2016). This evidence concerns the gene ACE and diabetes mellitus.